Stay updated on Tucatinib Combo in Advanced HER2+ Breast Cancer Clinical Trial

Sign up to get notified when there's something new on the Tucatinib Combo in Advanced HER2+ Breast Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Tucatinib Combo in Advanced HER2+ Breast Cancer Clinical Trial page

  1. Check
    7 days ago
    No Change Detected
  2. Check
    14 days ago
    Change Detected
    Summary
    The website has been updated from version 2.10.3 to 2.11.0, indicating a new release with potential enhancements or features.
    Difference
    0.1%
    Check dated 2024-09-19T22:17:16.000Z thumbnail image
  3. Check
    23 days ago
    No Change Detected
  4. Check
    30 days ago
    Change Detected
    Summary
    The website has been updated from version 2.10.2 to 2.10.3, indicating a new release.
    Difference
    0.0%
    Check dated 2024-09-04T05:37:32.000Z thumbnail image
  5. Check
    37 days ago
    No Change Detected
  6. Check
    51 days ago
    Change Detected
    Summary
    The website has been updated from version 2.10.0 to 2.10.2, indicating new features or improvements.
    Difference
    0.0%
    Check dated 2024-08-14T00:13:45.000Z thumbnail image
  7. Check
    71 days ago
    Change Detected
    Summary
    The study has expanded to include 176 locations and has been updated from revision v2.9.7 to v2.10.0.
    Difference
    0.2%
    Check dated 2024-07-24T16:17:05.000Z thumbnail image
  8. Check
    80 days ago
    Change Detected
    Summary
    The website has been updated to Revision v2.9.7 from v2.9.6.
    Difference
    0.0%
    Check dated 2024-07-16T09:38:36.000Z thumbnail image
  9. Check
    92 days ago
    Change Detected
    Summary
    The value of the publication has been updated to include new findings related to the preservation of quality of life in patients with HER2-positive metastatic breast cancer treated with tucatinib or placebo in combination with trastuzumab and capecitabine, as well as intracranial efficacy and survival data from the HER2CLIMB trial.
    Difference
    0.0%
    Check dated 2024-07-03T16:11:08.000Z thumbnail image

Stay in the know with updates to Tucatinib Combo in Advanced HER2+ Breast Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Tucatinib Combo in Advanced HER2+ Breast Cancer Clinical Trial page.